Evaluation of Wear Experience With a Weekly Replacement Soft Contact Lens in Neophyte Lens Wearers With Astigmatism

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This open-label study is of adults with astigmatism who have never worn contact lenses. Subjects will be fit into a one week planned-replacement contact lenses and will wear lenses for approximately 3 weeks. Subjects will return for vision and lens fit assessments and will complete surveys about their wear experience.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 40
Healthy Volunteers: t
View:

• Subjects must be new to contact lenses and have astigmatism of -0.75 or greater (within the parameters available for the P7fA lenses)

• Subjects must have 20/20 or better best corrected visual acuity.

• Good general health (defined by medication use that has not changed within the last month and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the PI)

• Ability to give informed consent

• Willing to spend time for the study. Subjects will be required to attend three study visits and wear contact lenses on days between study visits.

• Willing and able to wear contact lenses for at least 8 hours per day for 5 days per week during the study as daily wear.

• Currently not using eye lubricating drops and willing to not use during study.

• Either gender and 18-40 years of age.

• Any racial or ethnic origin

Locations
United States
Ohio
The Ohio State University College of Optometry
RECRUITING
Columbus
Contact Information
Primary
Emma Grant
grant.845@osu.edu
614-292-8858
Backup
Jennifer Fogt
fogt.78@osu.edu
614-292-0882
Time Frame
Start Date: 2025-01-21
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 60
Treatments
Experimental: Contact Lens Wear Experience
One week replacement soft contact lenses will be worn for 3 weeks.
Related Therapeutic Areas
Sponsors
Collaborators: Alcon Research
Leads: Ohio State University

This content was sourced from clinicaltrials.gov